FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2331509318> ?p ?o ?g. }

• W2331509318 abstract "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, ILBackground: Each year, approximately 60,000 patients in the US are diagnosed with locally advanced non-small cell lung carcinoma (NSCLC). The majority is treated with a combination of radiation therapy (RT), chemotherapy +/− surgery. Despite best available therapy, over a third of patients fail locoregionally. The addition of concurrent chemotherapy to RT adds only about a 5% absolute survival benefit. Novel radiosensitizers may improve the therapeutic index of RT. Materials and Methods: We performed whole genome pooled RNAi screens using the Hannon-Elledge library of 74,705 distinct shRNAs directed against over 18,000 genes, in two NSCLC cell lines A549 and NCI-H460. After stable transduction, we passaged the lines for 12 population doublings, and extracted DNA both before and after passaging to compare the representation of each shRNA at each time point. We defined top hits as those genes for which multiple shRNAs decreased in representation by at least 50% during passaging, signifying silencings that were detrimental to proliferation. Results: The top hit of our screen was PSMA1, a subunit of the 20S proteasome; out of six shRNAs, between four and six scored in the two lines in screens performed in triplicate. Bortezomib, an inhibitor of the 20S proteasome, has shown activity against NSCLC in preclinical studies and Phase I/II clinical trials. We observed that bortezomib results in synergistic cytotoxicity in cells treated with fractionated ionizing radiation (IR) in vitro. 10 nM bortezomib resulted in 46% clonogenic survival of unirradiated A549 cells, but only 29% survival of cells treated with 1 Gy x 3 daily fractions compared to cells treated with IR alone. Similar results were observed with MG-132 and with NCI-H460. In soft agar anchorage-independent growth assays, bortezomib resulted in less than 1% colony formation following 1 Gy x 3 daily fractions compared to cells treated with IR alone. In vivo experiments are underway with subcutaneous xenografts in nude mice treated with concurrent CT-guided conformal RT. A retrospective analysis of 443 patients with profiled lung adenocarcinomas showed worse overall survival among patients with tumors showing high proteasome gene expression (median OS 4.2 vs. 6.2 y, 5-year OS 47.5 vs. 61.0%, log rank p = 0.04). Conclusions: Proteasome inhibition emerged as the top drug target of an RNAi screen designed to identify targets with sustained activity over multiple cell generations. Its synergistic impact on NSCLC viability when coupled with fractionated RT should be further explored in preclinical studies and early clinical trials.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1448. doi:1538-7445.AM2012-1448" @default.
• W2331509318 created "2016-06-24" @default.
• W2331509318 creator A5001031272 @default.
• W2331509318 creator A5030930226 @default.
• W2331509318 creator A5036360705 @default.
• W2331509318 creator A5040257921 @default.
• W2331509318 creator A5044001206 @default.
• W2331509318 creator A5044648110 @default.
• W2331509318 creator A5051581826 @default.
• W2331509318 creator A5069554628 @default.
• W2331509318 creator A5075835176 @default.
• W2331509318 creator A5075890039 @default.
• W2331509318 date "2012-04-15" @default.
• W2331509318 modified "2023-09-27" @default.
• W2331509318 title "Abstract 1448: Whole genome RNAi screen identifies proteasome inhibition as a strategy for NSCLC radiosensitization" @default.
• W2331509318 doi "https://doi.org/10.1158/1538-7445.am2012-1448" @default.
• W2331509318 hasPublicationYear "2012" @default.
• W2331509318 type Work @default.
• W2331509318 sameAs 2331509318 @default.
• W2331509318 citedByCount "0" @default.
• W2331509318 crossrefType "proceedings-article" @default.
• W2331509318 hasAuthorship W2331509318A5001031272 @default.
• W2331509318 hasAuthorship W2331509318A5030930226 @default.
• W2331509318 hasAuthorship W2331509318A5036360705 @default.
• W2331509318 hasAuthorship W2331509318A5040257921 @default.
• W2331509318 hasAuthorship W2331509318A5044001206 @default.
• W2331509318 hasAuthorship W2331509318A5044648110 @default.
• W2331509318 hasAuthorship W2331509318A5051581826 @default.
• W2331509318 hasAuthorship W2331509318A5069554628 @default.
• W2331509318 hasAuthorship W2331509318A5075835176 @default.
• W2331509318 hasAuthorship W2331509318A5075890039 @default.
• W2331509318 hasConcept C104317684 @default.
• W2331509318 hasConcept C117262875 @default.
• W2331509318 hasConcept C121608353 @default.
• W2331509318 hasConcept C126322002 @default.
• W2331509318 hasConcept C143998085 @default.
• W2331509318 hasConcept C166703698 @default.
• W2331509318 hasConcept C173396325 @default.
• W2331509318 hasConcept C190232843 @default.
• W2331509318 hasConcept C27740335 @default.
• W2331509318 hasConcept C2776256026 @default.
• W2331509318 hasConcept C2776364478 @default.
• W2331509318 hasConcept C2777478702 @default.
• W2331509318 hasConcept C2778367456 @default.
• W2331509318 hasConcept C2908647359 @default.
• W2331509318 hasConcept C502942594 @default.
• W2331509318 hasConcept C54355233 @default.
• W2331509318 hasConcept C67705224 @default.
• W2331509318 hasConcept C71924100 @default.
• W2331509318 hasConcept C81885089 @default.
• W2331509318 hasConcept C86803240 @default.
• W2331509318 hasConcept C99454951 @default.
• W2331509318 hasConceptScore W2331509318C104317684 @default.
• W2331509318 hasConceptScore W2331509318C117262875 @default.
• W2331509318 hasConceptScore W2331509318C121608353 @default.
• W2331509318 hasConceptScore W2331509318C126322002 @default.
• W2331509318 hasConceptScore W2331509318C143998085 @default.
• W2331509318 hasConceptScore W2331509318C166703698 @default.
• W2331509318 hasConceptScore W2331509318C173396325 @default.
• W2331509318 hasConceptScore W2331509318C190232843 @default.
• W2331509318 hasConceptScore W2331509318C27740335 @default.
• W2331509318 hasConceptScore W2331509318C2776256026 @default.
• W2331509318 hasConceptScore W2331509318C2776364478 @default.
• W2331509318 hasConceptScore W2331509318C2777478702 @default.
• W2331509318 hasConceptScore W2331509318C2778367456 @default.
• W2331509318 hasConceptScore W2331509318C2908647359 @default.
• W2331509318 hasConceptScore W2331509318C502942594 @default.
• W2331509318 hasConceptScore W2331509318C54355233 @default.
• W2331509318 hasConceptScore W2331509318C67705224 @default.
• W2331509318 hasConceptScore W2331509318C71924100 @default.
• W2331509318 hasConceptScore W2331509318C81885089 @default.
• W2331509318 hasConceptScore W2331509318C86803240 @default.
• W2331509318 hasConceptScore W2331509318C99454951 @default.
• W2331509318 hasLocation W23315093181 @default.
• W2331509318 hasOpenAccess W2331509318 @default.
• W2331509318 hasPrimaryLocation W23315093181 @default.
• W2331509318 hasRelatedWork W1482635606 @default.
• W2331509318 hasRelatedWork W1519836038 @default.
• W2331509318 hasRelatedWork W1524610561 @default.
• W2331509318 hasRelatedWork W1988209788 @default.
• W2331509318 hasRelatedWork W1991428405 @default.
• W2331509318 hasRelatedWork W2013990257 @default.
• W2331509318 hasRelatedWork W2016986129 @default.
• W2331509318 hasRelatedWork W2031226846 @default.
• W2331509318 hasRelatedWork W2089310800 @default.
• W2331509318 hasRelatedWork W2313494287 @default.
• W2331509318 hasRelatedWork W2317731767 @default.
• W2331509318 hasRelatedWork W2321130406 @default.
• W2331509318 hasRelatedWork W2325262412 @default.
• W2331509318 hasRelatedWork W2336303364 @default.
• W2331509318 hasRelatedWork W2345144840 @default.
• W2331509318 hasRelatedWork W2493567107 @default.
• W2331509318 hasRelatedWork W2562592912 @default.
• W2331509318 hasRelatedWork W2887201603 @default.
• W2331509318 hasRelatedWork W2955954677 @default.
• W2331509318 hasRelatedWork W3083351885 @default.
• W2331509318 isParatext "false" @default.
• W2331509318 isRetracted "false" @default.
• W2331509318 magId "2331509318" @default.
• W2331509318 workType "article" @default.